Dr. Mitchell B. Strominger, MD

Dr. Strominger practices at Renown Regional Medical Center in Reno, Nevada, part of Renown Health.

Dr. Strominger's NPI, 1528026184, was assigned on May 3, 2006. Dr. Strominger graduated from WashU Medicine in 1986. Dr. Strominger holds Nevada license 18310.

Dr. Strominger's primary practice is Renown Regional Medical Center, at 1155 Mill Street, Reno, NV 89502 in Washoe County. The practice phone is (775) 982-4100.

Dr. Strominger's primary practice is Renown Regional Medical Center in Reno, Nevada, part of Renown Health. Dr. Strominger is also affiliated with Renown South Meadows Medical Center. The medical group on file is Renown Health. Dmand AI also links Dr. Strominger to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Strominger practices, 3 sites in all. Vendor and product names are available with a free account.

Neuro-ophthalmology is Dr. Strominger's primary specialty in the NPI Registry, under taxonomy code 207WX0109X. Dr. Strominger is board certified in fellow by the American academy of pediatrics. Dmand AI has Dr. Strominger's licenses on file in 5 states: Nevada, Florida, Massachusetts, New York and New Jersey.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, glaucoma, retinal occlusion and vision problems among the conditions Dr. Strominger treats.

CMS data shows 440 Medicare services from Dr. Strominger across 6 procedure codes in 2024, for 141 Medicare patients. Medicare paid $25,139 for them. Every service was in an office.

CMS counts 141 Medicare patients who saw Dr. Strominger in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Strominger's median patient age at 10, with 59% women.

In 2024, Dr. Strominger wrote 56 Medicare Part D claims for 21 patients. 77% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $60 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Strominger for performance year 2024, reported as part of a group. Dr. Strominger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to Dr. Strominger, published from 2013 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Oculomotor Muscles, Ophthalmologic Surgical Procedures and Strabismus. Dr. Strominger has published most often in J Pediatr Ophthalmol Strabismus. Dr. Strominger's most frequent co-authors are Rudolph Steven Wagner, MD, Linda R. Dagi, MD and Sean P. Donahue, MD, PhD.

CMS Open Payments shows 137 general payments to Dr. Strominger from 16 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 37% of the total. Amgen Inc. paid the most, $35,897.

Dmand AI lists 7 awards for Dr. Strominger, most recently Boston Magazine in 2013.

Dr. Strominger graduated from WashU Medicine in 1986. Dr. Strominger is a member of AAO.

Dr. Strominger is in network with 11 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.